Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gut microbiome modulates tacrolimus pharmacokinetics through the transcriptional regulation of ABCB1
Authors
Keywords
-
Journal
Microbiome
Volume 11, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-07-06
DOI
10.1186/s40168-023-01578-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Antibiotics-induced depletion of rat microbiota induces changes in the expression of host drug-processing genes and pharmacokinetic behaviors of CYPs probe drugs
- (2023) Haijun Yang et al. DRUG METABOLISM AND DISPOSITION
- OPTN/SRTR 2020 Annual Data Report: Kidney
- (2022) K. L. Lentine et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Rethinking healthy eating in light of the gut microbiome
- (2022) Anissa M. Armet et al. Cell Host & Microbe
- Bacillus subtilis plays a role in the inhibition of transporter ABCB1 in Caco-2 cells
- (2022) Yuanyuan Dai et al. EPILEPSY RESEARCH
- Microbial Metabolites Orchestrate a Distinct Multi-Tiered Regulatory Network in the Intestinal Epithelium That Directs P-Glycoprotein Expression
- (2022) Sage E. Foley et al. mBio
- Multi‐compartment metabolomics and metagenomics reveal major hepatic and intestinal disturbances in cancer cachectic mice
- (2021) Sarah A. Pötgens et al. Journal of Cachexia Sarcopenia and Muscle
- CAR directs T cell adaptation to bile acids in the small intestine
- (2021) Mei Lan Chen et al. NATURE
- Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs
- (2021) Yusuke Kono et al. Pharmaceutics
- Gut microbiota regulation of P-glycoprotein in the intestinal epithelium in maintenance of homeostasis
- (2021) Sage E. Foley et al. Microbiome
- Combinatorial, additive and dose-dependent drug–microbiome associations
- (2021) Sofia K. Forslund et al. NATURE
- Impact of gut microbiota on kidney transplantation
- (2021) Poramed Winichakoon et al. Transplantation Reviews
- A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation
- (2020) Haley M. Gonzales et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Butyric acid normalizes hyperglycemia caused by the tacrolimus‐induced gut microbiota
- (2020) Wenjiao Jiao et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Interaction between drugs and the gut microbiome
- (2020) Rinse K Weersma et al. GUT
- Personalized Mapping of Drug Metabolism by the Human Gut Microbiome
- (2020) Bahar Javdan et al. CELL
- Predictors of tacrolimus pharmacokinetic variability: current evidences and future perspectives
- (2020) Alexandra Degraeve et al. Expert Opinion on Drug Metabolism & Toxicology
- Commensal gut bacteria convert the immunosuppressant tacrolimus to less potent metabolites
- (2019) Yukuang Guo et al. DRUG METABOLISM AND DISPOSITION
- Nutritional Management in Renal Transplant Recipients: A transplant team opportunity to improve graft survival
- (2019) M. Sabbatini et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Mapping human microbiome drug metabolism by gut bacteria and their genes
- (2019) Michael Zimmermann et al. NATURE
- Immunosuppressive effect of the gut microbiome altered by high-dose tacrolimus in mice
- (2018) Z. Zhang et al. AMERICAN JOURNAL OF TRANSPLANTATION
- High tacrolimus intra-patient variability is associated with graft rejection, and de novo donor-specific antibodies occurrence after liver transplantation
- (2018) Arnaud Del Bello et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Gut Microbiota-Mediated Bile Acid Transformations Alter the Cellular Response to Multidrug Resistant Transporter Substrates in Vitro: Focus on P-glycoprotein
- (2018) Elaine F. Enright et al. MOLECULAR PHARMACEUTICS
- In Vitro Assessment of the Effect of Antiepileptic Drugs on Expression and Function of ABC Transporters and Their Interactions with ABCC2
- (2017) Gurpreet Grewal et al. MOLECULES
- The combination of CYP3A4*22 and CYP3A5*3 single-nucleotide polymorphisms determines tacrolimus dose requirement after kidney transplantation
- (2017) Nuria Lloberas et al. Pharmacogenetics and Genomics
- Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen
- (2017) Gianluigi Zaza et al. PLoS One
- Microbiome Datasets Are Compositional: And This Is Not Optional
- (2017) Gregory B. Gloor et al. Frontiers in Microbiology
- Caco-2 cells - expression, regulation and function of drug transporters compared with human jejunal tissue
- (2016) S. Brück et al. BIOPHARMACEUTICS & DRUG DISPOSITION
- The microbial pharmacists within us: a metagenomic view of xenobiotic metabolism
- (2016) Peter Spanogiannopoulos et al. NATURE REVIEWS MICROBIOLOGY
- Pharmacogenetic-based strategy using de novo tacrolimus once daily after kidney transplantation: prospective pilot study
- (2016) Martine De Meyer et al. PHARMACOGENOMICS
- Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota
- (2015) Kristoffer Forslund et al. NATURE
- Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
- (2015) Renata Silva et al. PHARMACOLOGY & THERAPEUTICS
- Intra-patient variability in tacrolimus exposure: Causes, consequences for clinical management
- (2015) Nauras Shuker et al. Transplantation Reviews
- Gut Microbiota and Tacrolimus Dosing in Kidney Transplantation
- (2015) John R. Lee et al. PLoS One
- Symbiotic Bacterial Metabolites Regulate Gastrointestinal Barrier Function via the Xenobiotic Sensor PXR and Toll-like Receptor 4
- (2014) Madhukumar Venkatesh et al. IMMUNITY
- ABCB1 1199G>A Genetic Polymorphism (Rs2229109) Influences the Intracellular Accumulation of Tacrolimus in HEK293 and K562 Recombinant Cell Lines
- (2014) Géraldine Dessilly et al. PLoS One
- Gut Microbial Community Structure and Complications After Kidney Transplantation
- (2014) John R. Lee et al. TRANSPLANTATION
- Effects of CYP3A4 and CYP3A5 polymorphisms on tacrolimus pharmacokinetics in Chinese adult renal transplant recipients
- (2013) Xiao-cong Zuo et al. Pharmacogenetics and Genomics
- Commensal Bacteria Control Cancer Response to Therapy by Modulating the Tumor Microenvironment
- (2013) N. Iida et al. SCIENCE
- Analysis of gut microbial regulation of host gene expression along the length of the gut and regulation of gut microbial ecology through MyD88
- (2011) Erik Larsson et al. GUT
- Depletion of Murine Intestinal Microbiota: Effects on Gut Mucosa and Epithelial Gene Expression
- (2011) Dag Henrik Reikvam et al. PLoS One
- Colonization-Induced Host-Gut Microbial Metabolic Interaction
- (2011) S. P. Claus et al. mBio
- Clinical Pharmacokinetics of Tacrolimus after the First Oral Administration in Renal Transplant Recipients on Triple Immunosuppressive Therapy
- (2010) Radmila M. Velickovic-Radovanovic et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Elevated Tacrolimus Levels Associated With Intravenous Azithromycin and Ceftriaxone: A Case Report
- (2010) M.A. Shullo et al. TRANSPLANTATION PROCEEDINGS
- Involvement of Vitamin D Receptor in the Intestinal Induction of Human ABCB1
- (2009) S. Tachibana et al. DRUG METABOLISM AND DISPOSITION
- Intestinal flora induces the expression of Cyp3a in the mouse liver
- (2009) T. Toda et al. XENOBIOTICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search